First-in-human CAR T targets MUC1 transmembrane cleavage product.

被引：0
|
作者：
Bamdad, Cynthia [1 ]
Stewart, Andrew K. [1 ]
Huang, Pengyu [1 ]
Smagghe, Benoit J. [1 ]
Moe, Scott T. [1 ]
Swanson, Tyler E. [1 ]
Jeon, Thomas G. [1 ]
Page, Danica M. [1 ]
Grant, Trevor J. [1 ]
Specht, Jennifer M. [2 ]
机构：
[1] Minerva Biotechnol, Waltham, MA USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
57
引用
收藏
页数：2
相关论文
共 50 条
  • [41] CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
    Zhou, Ru
    Yazdanifar, Mahboubeh
    Das Roy, Lopamudra
    Whilding, Lynsey M.
    Gavrill, Artemis
    Maher, John
    Mukherjee, Pinku
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [42] Targeted immuotherapy of Muc1 positive carcinomas with genetically engineered human T cells.
    Chinnasamy, Nachimuthu
    Shaffer, James
    Chinnasamy, Dhanalakshmi
    BLOOD, 2006, 108 (11) : 1062A - 1062A
  • [43] Development of Engineered CAR T Cells Targeting Tumor-Associated Glycoforms of MUC1 for the Treatment of Intrahepatic Cholangiocarcinoma
    Mao, Li
    Su, Sheng
    Li, Jia
    Yu, Songyang
    Gong, Yu
    Chen, Changzhou
    Hu, Zhiqiang
    Huang, Xiaowu
    JOURNAL OF IMMUNOTHERAPY, 2023, 46 (03) : 89 - 95
  • [44] MUC1 in human milk blocks transmission of human immunodeficiency virus from dendritic cells to T cells
    Saeland, Eirikur
    de Jong, Marein A. W. P.
    Nabatov, Alexey A.
    Kalay, Hakan
    Geijtenbeek, Teunis B. H.
    van Kooyk, Yvette
    MOLECULAR IMMUNOLOGY, 2009, 46 (11-12) : 2309 - 2316
  • [45] PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells
    Wei, Xinru
    Lai, Yunxin
    Li, Jin
    Qin, Le
    Xu, Youdi
    Zhao, Ruocong
    Li, Baiheng
    Lin, Simiao
    Wang, Suna
    Wu, Qiting
    Liang, Qiubin
    Peng, Muyun
    Yu, Fenglei
    Li, Yangqiu
    Zhang, Xuchao
    Wu, Yilong
    Liu, Pentao
    Pei, Duanqing
    Yao, Yao
    Li, Peng
    ONCOIMMUNOLOGY, 2017, 6 (03):
  • [46] MUC1 is a novel costimulatory molecule of human T cells and functions in an AP-1-dependent manner
    Konowalchuk, Jeffrey D.
    Agrawal, Babita
    HUMAN IMMUNOLOGY, 2012, 73 (05) : 448 - 455
  • [47] First-in-human anti-ALPP CAR-T cell immunotherapy for ovarian and endometrial cancer
    Zhu, B.
    Jia, Q.
    Chen, R.
    Chen, G.
    Zhao, L.
    Palmer, N.
    Xiang, D.
    Chen, F.
    Duan, Y.
    Wang, H.
    Shan, J.
    Xiong, L.
    Xie, R.
    Li, G.
    Yan, L.
    Li, R.
    Xia, L.
    Su, Z.
    Alexander, P.
    Li, S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S807 - S807
  • [48] Tumor MUC1 glycoprotein-highly specific CAR T cells control triple-negative breast cancer
    Zhou, Ru
    Yazdanifar, Mahboubeh
    Das Roy, Lopamudra
    Maher, John
    Mukherjee, Pinku
    CANCER RESEARCH, 2019, 79 (13)
  • [49] Prediction of First-in-Human Dose of Chimeric Antigen Receptor-T (CAR-T) Cells from Mice
    Mahmood, Iftekhar
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (06) : 715 - 722
  • [50] A first-in-human clinical trial of GMR CAR-T for CD116+ myeloid malignancies
    Saito, Shoji
    Nakazawa, Yozo
    CANCER SCIENCE, 2022, 113 : 649 - 649
12345